{
  "docId": "019de075-1362-766d-ac60-1333cab868aa",
  "docSlug": "7fe2865adefd4e627357f5c080658aba",
  "documentTitle": "Alkermes | Investor Presentation Deck | 56 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 56,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a mix of bar charts for annual revenue and a line chart for weekly prescription growth.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-1362-766d-ac60-1333cab868aa/18",
  "deckHref": "/decks/019de075-1362-766d-ac60-1333cab868aa",
  "deckJsonHref": "/decks/019de075-1362-766d-ac60-1333cab868aa.json",
  "deckAnchorHref": "/decks/019de075-1362-766d-ac60-1333cab868aa#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.52,
        "y": 0.175
      },
      "kind": "chart",
      "text": "ARISTADA Growth Outpaced the aLAI Market",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8788f318-6200-4dfa-b2b6-6504f8b8c111",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.05,
        "y": 0.175
      },
      "kind": "chart",
      "text": "Re-Established VIVITROL Growth After COVID-19 Disruption",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae77aa99-5df7-4844-95bf-cb92855a8071",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.52,
        "y": 0.52
      },
      "kind": "chart",
      "text": "Strong VUMERITY CAGR Since Launch",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c78a92df-3b2c-4f7a-9fd0-00a27f43c785",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.05,
        "y": 0.52
      },
      "kind": "chart",
      "text": "Strong LYBALVI TRx Growth Since Launch",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "87e4ea62-1019-472c-aa2c-5fcf347d57b1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "Source: IQVIA NPA Weekly through 5/19/23; Reflects broker consensus estimates for 2023E as of June 1, 2023",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b94bb5f2-1b36-48a7-9af0-5a3d5efeb9e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "3 Execution Has Yielded Significant Growth Across Our Portfolio",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5ed33618-a6d6-4a70-b0e2-e3cc295f572b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "93d84151-1b26-4cc7-90b4-a1dbed0c0fe2",
      "evidence": "chart/bar-vertical: Re-Established VIVITROL Growth After COVID-19 Disruption",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 13,
      "beatId": "456ee3e4-026a-442c-9438-289bfd81ee8a",
      "arcName": "The Transformation Tale",
      "arcSlug": "transformation-tale",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Slides 13-20 provide evidence of Alkermes' successful execution and growth.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 17,
      "name": "Mece Breakdown",
      "slug": "40-mece-breakdown",
      "bestFor": "Problem structuring, ensuring completeness, strategic analysis",
      "matchId": "8c753e0f-bc7c-4296-afd3-cccb0d4a6d82",
      "evidence": "Slides 17-20 provide a MECE breakdown of Alkermes' growth and profitability.",
      "position": 1,
      "objective": "Break down Alkermes' growth and profitability drivers",
      "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage",
      "confidence": 0.6,
      "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}